Lv1
72 积分 2023-12-19 加入
Response-Adapted Surgical and Radiotherapy De-Escalation in Resectable Cutaneous Squamous Cell Cancer Using Pembrolizumab: The De-Squamate Study
18天前
已完结
Response-Adapted Surgical and Radiotherapy De-Escalation in Resectable Cutaneous Squamous Cell Cancer Using Pembrolizumab: The De-Squamate Study
25天前
已关闭
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase Ib/II dose-escalation and dose-expansion study
1个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
1个月前
已完结
Navigating the Evolving Landscape of EGFR -Mutated NSCLC
1个月前
已完结
Surgical Outcome and Long-Term Survival of Conversion Surgery for Advanced Gastric Cancer
2个月前
已完结
Treatment strategy for successful conversion surgery in clinical stage IVB gastric cancer
2个月前
已完结
Induction of a Pathological Complete Response by Four Courses of Neoadjuvant Chemotherapy for Gastric Cancer: Early Results of the Randomized Phase II COMPASS Trial
2个月前
已完结
Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer
3个月前
已完结
Radiomics and Deep Learning in Nasopharyngeal Carcinoma: A Review
3个月前
已完结
皖公网安备34019202002308
